Experience

William Oak Diagnostics

• United Kingdom
• Medical Equipment Manufacturing
• 1 - 100 Employee

• CTO and Co-Founder

  • Jan 2023 - Present

  Cambridge, England, United Kingdom Our vision is to eliminate micronutrient deficiencies as a healthcare concern for mother and baby. Our innovative point-of-care test with integrated blood-collection simplifies the identification of various micronutrient deficiencies. With just a push of a button, we are making maternal, child, and infant testing more accessible.



Blackcliffs Consulting

• Managing Director

  • Nov 2022 - Present

  Kettering, England, United Kingdom Founder and Director of Blackcliffs Consulting, an independent technology and management consultancy service that offers bespoke management and operational support to a range of start-up and established UK and EU technology companies. Working with a network of consulting and technology professionals, the company has various ongoing contracts in areas including; biotechnology, medical device design and development, operational strategy, change management, leadership development, company… Show more Founder and Director of Blackcliffs Consulting, an independent technology and management consultancy service that offers bespoke management and operational support to a range of start-up and established UK and EU technology companies. Working with a network of consulting and technology professionals, the company has various ongoing contracts in areas including; biotechnology, medical device design and development, operational strategy, change management, leadership development, company formation and fundraising. Show less



Global Access Dx (GADx) (formerly Mologic)

• Chief Technology Officer

  • Jan 2019 - Nov 2022

  Bedfordshire As CTO, responsible for the company’s commercial and internal R&D, Quality, HR, H&S, Manufacturing and Operational functions, as well as shaping technology, operational and scientific strategy. This included strategic, operational and technical oversight of c.55 customer and internal programmes whilst building and fostering customer relationships, strategic collaborations, and generating new business.



AgPlus Diagnostics Ltd

• United Kingdom
• Medical Equipment Manufacturing
• 1 - 100 Employee

• Research and Development Director

  • Jul 2014 - Dec 2018

  Sharnbrook, Bedfordshire Also served as Company Director and Board Member of AgPlus Diagnostics Ltd. (2016 – 2018) As Research and Development Director; responsible for leading and delivering all R&D activities related to the AgPlus point-of-care platform technology, external collaborations, customer projects as well as the recruitment, retention and leadership of all scientific staff. As a member of the board; driving and monitoring the overall strategy and direction of the company during numerous growth and… Show more Also served as Company Director and Board Member of AgPlus Diagnostics Ltd. (2016 – 2018) As Research and Development Director; responsible for leading and delivering all R&D activities related to the AgPlus point-of-care platform technology, external collaborations, customer projects as well as the recruitment, retention and leadership of all scientific staff. As a member of the board; driving and monitoring the overall strategy and direction of the company during numerous growth and structural change stages. Show less



Novartis

• Switzerland
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Fellow

  • Jan 2013 - Jul 2014

  Sittingbourne, Kent Leading the feasibility/proof of concept group in the newly formed Near Patient Testing Unit. Working with the drug development teams to design novel point-of-care diagnostic tests, based on the acquired Vivacta technology, and to drive and support their use as companion diagnostics.



Vivacta

• Medical Device
• 1 - 100 Employee

• R&D Team Leader

  • 2007 - 2012

  Sittingbourne Sequentially responsible for leading the chemistry development, assay development and research teams focusing on developing and improving the company’s novel immunoassay platform technology. Vivacta was aquired by Novartis in January 2013.



Oxonica

• Nanotechnology Research
• 1 - 100 Employee

• Senior Biodiagnostic Development Scientist

  • 2005 - 2007

  Oxford, United Kingdom Responsible for the application of Oxonica’s novel nanoparticle detection system to biodiagnostic testing and leading the design and development of Oxonica’s immunoassay platform technology.



Oxford Immunotec

• United Kingdom
• Biotechnology Research
• 100 - 200 Employee

• Development Scientist/Project Leader

  • 2003 - 2005

  Oxford, United Kingdom One of the founding Scientists of Oxford Immunotec, and subsequently responsible for developing the company’s first and second generation products, novel diagnostic devices for the detection of tuberculosis, the first of which received a CE mark in 2004 and FDA approval in 2008.



Synaptica

• United States
• Software Development
• 1 - 100 Employee

• Scientist

  • 2003 - 2003

  Oxford, United Kingdom Responsible for designing and developing novel immunological and biochemical assays. Specifically, assays to establish the presence of macromolecules in physiological samples from patients suffering with Alzheimer’s disease.



Microscience Ltd

• United Kingdom
• Writing and Editing

• Analytical Development Scientist

  • 2001 - 2003

  Reading, United Kingdom Working within the typhoid vaccine group responsible for; Immunological and microbial assay design, development and validation, specifically, pre-clinical and clinical immunoassays (ELISA) and stability and characterisation testing on manufactured batches of vaccine product.



Oxford GlycoSciences (UK) Limited

• United Kingdom
• Biotechnology Research

• Production/Laboratory Technician

  • 2000 - 2001

  Oxford, United Kingdom